Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts
Rory M. Shallis(Smilow Cancer Hospital), Amer M. Zeidan(Yale Cancer Center), Pau Montesinos(Instituto de Salud Carlos III), Amir T. Fathi(University of Southern California), Rami S. Komrokji(Moffitt Cancer Center), Roland B. Walter(Rafael Advanced Defense Systems (Israel)), Maximilian Stahl(Harvard University), Hetty E. Carraway(Cleveland Clinic), Stéphane de Botton(Université Paris-Saclay), Laura C. Michaelis(Medical College of Wisconsin), Alice S. Mims(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jessica K. Altman(Northwestern University), Sylvie Freeman(University of Birmingham), Daniel A. Pollyea(University of Colorado Denver), Adolfo de la Fuente Burguera(MD Anderson Cancer Center Madrid), Tara L. Lin(Dana-Farber Cancer Institute), Naval Daver(The University of Texas MD Anderson Cancer Center), Eunice S. Wang(Roswell Park Comprehensive Cancer Center), Joshua F. Zeidner(University of North Carolina at Chapel Hill), Michael R. Grunwald(Levine Cancer Institute), Keith W. Pratz(University of Pennsylvania), Ivana Gojo(Johns Hopkins University), Firas El Chaer(The University of Texas MD Anderson Cancer Center), Vijaya Raj Bhatt(Susan Thompson Buffett Foundation), Mikkael A. Sekeres(University of Miami), Andrius Žučenka(Vilnius University), Maria Teresa Voso(University of Rome Tor Vergata), Brian A. Jonas(Cellular Therapeutics (United Kingdom)), John Mascarenhas(Tisch Hospital), Pinkal Desai(NewYork–Presbyterian Hospital), Talha Badar(Mayo Clinic in Florida), Nicolas Duployez(Inserm), Jan Philipp Bewersdorf(Memorial Sloan Kettering Cancer Center), Gabriel N. Mannis(Stanford University), Catherine C. Smith(University of California, San Francisco), Geoffrey L. Uy(Memorial Sloan Kettering Cancer Center), Marion Subklewe(LMU Klinikum), Olga Pozdnyakova(Brigham and Women's Hospital), Richard Dillon(King's College London), Marina Konopleva(Albert Einstein College of Medicine), Andre C. Schuh(University of Toronto)
Cited by 18
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k